Back to Journal

Annals of Chromatography and Separation Techniques

Reverse Phase High Performance Liquid Chromatographic Method for Separation and Estimation of Impurities Present in Pharmaceutical Formulation of Dapaglifozin

[ ISSN : 2473-0696 ]

Abstract Citation Introduction Material and Methods Method Validation Conclusion Acknowledgement References
Details

Received: 28-Dec-2017

Accepted: 15-Jan-2018

Published: 23-Jan-2018

Nilesh Patel* and Sejal Patel Shree S. K. Patel 

College of Pharmaceutical Education and Research, Ganpat University, India

Corresponding Author:

Nilesh Patel, Shree S.K.Patel College of Pharmaceutical Education and Research, Ganpat University, Ganpat Vidhyanagar-384012, Gujarat, India, Tel: +91 9033521696; Email: nilesh33.emcure@gmail.com

Keywords

Dapaglifozin; SGLT-2 Inhibitor; Zorbax Bonus RP-18; Stress condition; Impurities; ICH Q2 (R1)

Abstract

Dapaglifozin is a Sodium-glucose co-transporter-2 inhibitors work by inhibiting SGLT2, to prevent re absorption of glucose and facilitate its excretion in urine. Impurities in pharmaceuticals which are unwanted chemicals that remains with the Active Pharmaceutical Ingredients (APIs), or develop during stability testing, or develop during formulation or upon aging of both API and formulation. The presence of these unwanted chemicals even in small amounts may influence the efficacy and safety of the pharmaceutical products. It is necessary to estimate related impurities present in this drug. A simple and very sensitive method developed for estimation of impurities present in Dapagifozin formulation by Reverse Phase High Performance Liquid Chromatographic method. Method is capable to detect impurities in very low level (0.1µm/mL). Chromatographic separation of six different impurities was achieved on Agilent Zorbax Bonus RP-18 (250 x 4.6) mm, 5µm column using gradient elution method at 30°C column temperature and the detection was carried at 230 nm at a flow rate of 1.2mL/min. The method was validated as per ICH Q2 (R1) guideline along with stress studies.

Citation

Patel N and Patel S. Reverse Phase High Performance Liquid Chromatographic Method for Separation and Estimation of Impurities Present in Pharmaceutical Formulation of Dapaglifozin. Ann Chromatogr Sep Tech. 2018; 4(1): 1033.

Introduction

Dapaglifozin is a Sodium-glucose co-transporter-2 inhibitors work by inhibiting SGLT2 in the PCT, to prevent re-absorption of glucose and facilitate its excretion in urine. As glucose is excreted, its plasma levels fall leading to an improvement in all glycemic parameters. This mechanism of action is dependent on blood glucose levels and, unlike the actions of thiazolidinediones (mediated through GLUTs), is independent of the actions of insulin. Thus, there is minimal potential for hypoglycemia, and no risk of overstimulation or fatigue of the beta cells. Because their mode of action relies upon normal renal glomerular-tubular function, SGLT2i efficacy is reduced in persons with renal impairment (Figure 1).

Figure 1: Chemical Structure of Dapaglifozin.

Due to lots of advantages of Dapaglifozin, it is necessary to estimate related impurities present in these drug. So present investigation involve the development of RP-HPLC related substances method for pharmaceutical dosage form for Dapaglifozin. Possibly six impurities identified base on API source so separation was done on this impurities and validate developed method [1-6].

Impurities Details

(Tables 1 and 2)

Table 1: Details of Impurity-I to III.

Impurity Name

Impurity-I

Impurity-II

Impurity-III

 

 

 

 

 

Chemical Structure

 

 

 

 

Chemical Formula

C19H21ClO6

C21H25ClO6

C22H27ClO7

 

Chemical Name

(2S,3R,4R,5S,6R)-2-(4-Chloro-

3-(4-Hydroxy benzyl phenyl)-6- (hydroxylmethyl) tetrahydro-2H-pyran- 3,4,5-triol

(3R,4R,5R)-2-(4-Chloro-3-(4-ethoxybenzyl phenyl)-5-((R)-1,2-dihydroxyethyl) tetrahydofuran-3,4-diol

(3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl phenyl)-6-(hydroxyl methyl)-2-methoxy tetrahydro-2H-pyran-3,4,5-triol

Molecular Weight

380.82

408.88

438.9

Table 2: Details of Impurity-IV to VI.

Impurity Name

Impurity-IV

Impurity-V

Impurity-VI

 

 

 

 

 

Chemical Structure

 

 

 

 

Chemical Formula

C25H33ClO6

C15H15ClO

C15H14BrClO

 

Chemical Name

(2S,3R,4S,5S,6R)-2-butyl-2-(4-chloro-3-(4-

ethoxybenzyl)phenyl)-6-(hydroxymethyl) tetrahydro-2H-pyran-3,4,5-triol

 

1-chloro-2-(4-ethox y benzyl)benzene

4-bromo-1-chloro-2-(4- ethoxybenzyl)benzene

Molecular Weight

464.98

246.73

325.63

Material and Methods

Reagents and Chemicals

Dapaglifozin and its impurities were the generous gifts from MSN Laboratories PVT Ltd, India. HPLC grade Acetonitrile was procured from Merck. Potassium di-hydrogen phosphate (KH2 PO4 ) and ortho-phosphoric acid (H3 PO4) were purchased from Merck. All other chemicals and solvents used were of analytical grade. Water used in the HPLC analysis was prepared by the water purifier (Merck Millipore Milli-Q). The mobile phase and all the solutions were filtered through a 0.45µm Merck HV membrane filter. Sample was filtered through 0.45µm Millipore PVDF syringe filter.

Instruments

HPLC system (Waters system,USA,e2695) with a PDA detector, equipped with a quaternary pump,auto sampler,column compartment and empower software was employed during this study.

Chromatographic condition

Chromatographic separation was achieved at 30°C column temperature and the detection was carried at 230nm at a flow rate of 1.2mL/min. Run time was kept at 80 min. Prior to the injection of drug solution,column was equilibrated for 60 min with the mobile phase flowing through the system. The injection volume was 25μL. The analysis has been performed by using Agilent ZORBAX Bonus RP-18 (250×4.6 mm,5µ). The mobile phase A containing 50mM phosphate buffer adjusted pH 2.2 with ortho phosphoric acid solution and mobile phase B contains Acetonitrile and Methanol in ratio of (70:30)%v/v using following gradient (Table 3).

Table 3: Gradient Programme.

Time (Min) % Mobile Phase-A % Mobile Phase-B
0 80 20
2 80 20
22 60 40
40 40 60
60 20 80
70 20 80
75 80 20
80 80 20

Standard Preparation

The standard stock solutions 200ug/ml of Dapaglifozin was prepared by dissolving working standards in Diluent and diluting with the same solvent to obtain final concentration 4µg/mL.

Sample Preparation

Twenty tablets were weighed and finely powdered.Powder equivalent to 40mg Dapaglifozin was accurately weighed into a 100ml volumetric flask, 50ml of diluent was added and sonicated for 15min with intermittent shaking, made up to the volume with diluent and mixed. Filter the solution through 0.45µm Millipore PVDF syringe filter.

Method Validation

After method development, validation of the current test method for Dapaglifozin tablets was performed in accordance with United States Pharmacopeia requirements/ICH guidelines for related substance method the parameter includes precision, accuracy, linearity, LOD and LOQ, precision and accuracy at LOQ level, selectivity, specificity includes blank, placebo, known impurity interference and interference of degradants by degradation study. Robustness was also performed [7-13].

Specificity

To assess the method specificity, tablet powder without Dapaglifozin was prepared with the same excipients as those in the commercial formulation. For RP-HPLC, the solution was prepared using the same procedure as for the analytical sample. Placebo solution was injected into the HPLC system following test conditions, the chromatogram was recorded and the responses of the peaks if any measured. Chromatogram of the placebo has not shown any interference at the retention time of both Dapaglifozin and its impurities. Blank, placebo, and impurity spiked sample preparation and impurities mixture chromatogram shown in Figures 2-6.

Figure 2: Chromatogram of Diluent.

Figure 3: Chromatogram of Placebo.

Figure 4: Chromatogram of Impurity spiked sample.

Figure 5: Chromatogram of Overlay of Diluent, Placebo and Impurity spiked sample.

Figure 6: Chromatogram of Impurity mixture Solution.

System Suitability: 25μL of standard solution six times injected into HPLC and recorded the chromatogram,%RSD of Dapaglifozin, area was within the limit of 5.0%. The results summarized in Table 4 and standard solution chromatogram shown in Figure 7.

Figure 7: Chromatogram of Standard Solution.

Table 4: System suitability Result.

Injection No Peak Area of Theoretical Plates Tailing Factor
Dapaglifozin
1 116319 89802 1.1
2 117895 89682 1.1
3 116874 89005 1.1
4 115682 90105 1.1
5 116475 89744 1.1
6 116258 88975 1.1
Mean 116583.8    
SD 749    
%RSD 0.6    

Precision

Precision was measured in terms of repeatability of application and measurement. Repeatability of standard application (System precision). Precision study of Dapaglifozin and its impurities were carried out by spiking known concentration in sample and calculating % recovery of impurities in sample. Intermediate precision carried out using same manner but on other day using different column and HPLC. The results summarized in Tables 5 and 6.

Table 5: Method Precision.

SNo Impurity-I Impurity-II Impurity-III Impurity-IV Impurity-V Impurity-VI Single Max Unk Total Imp
1 0.52 0.92 0.75 0.59 0.67 0.6 0 4.05
2 0.52 0.92 0.75 0.59 0.67 0.6 0 4.05
3 0.52 0.93 0.75 0.58 0.66 0.6 0 4.04
4 0.51 0.92 0.75 0.59 0.67 0.6 0 4.04
5 0.52 0.92 0.75 0.6 0.67 0.61 0 4.07
6 0.52 0.91 0.75 0.59 0.67 0.61 0 4.05
Mean 0.52 0.92 0.75 0.59 0.67 0.6 0 4.05
SD 0.004 0.006 0 0.006 0.004 0.005 0 0.01
%RSD 0.8 0.7 0 1.1 0.6 0.9 0 0.3

Table 6: Intermediate Precision.

S.No Impurity-I Impurity-II Impurity-III Impurity-IV Impurity-V Impurity-VI Single Max Unk Total Imp
1 0.56 0.71 0.62 0.51 0.47 0.62 0 3.49
2 0.56 0.71 0.62 0.51 0.46 0.62 0 3.48
3 0.55 0.71 0.62 0.5 0.46 0.62 0 3.46
4 0.56 0.71 0.62 0.51 0.47 0.62 0 3.49
5 0.56 0.71 0.62 0.51 0.47 0.62 0 3.49
6 0.56 0.72 0.62 0.51 0.47 0.64 0 3.52
Mean 0.56 0.71 0.62 0.51 0.47 0.62 0 3.49
SD 0.004 0.004 0 0.004 0.005 0.008 0 0.02
%RSD 0.7 0.6 0 0.8 1.1 1.3 0 0.6

Linearity

To evaluate linearity of the method, six levels calibration curve made includes LOQ level. Signal to noise ratio was observed. The linearity of method is obtained by preparation of the calibration curve. The calibration curve for Dapaglifozin and its impurities were obtained by plotting the peak area of Dapaglifozin versus concentration of Dapaglifozin over the range of 0.30-16 μg/ml. The results are summarized and overall linearity graph for Dapaglifozin and its impurities was shown in Figures 8-14.

Figure 8: Linearity curve of Dapaglifozin.

Figure 9: Linearity curve of Impurity-I.

Figure 10: Linearity curve of Impurity-II.

Figure 11: Linearity curve of Impurity-III.

Figure 12: Linearity curve of Impurity-IV.

Figure 13: Linearity curve of Impurity-V.

Figure 14: Linearity curve of Impurity-VI.

Accuracy

Accuracy of the method was studied for three levels from 50% to 150% by spiking 0.05% for LOQ and 0.25% for 50% level from the target concentration of Dapaglifozin impurities and 0.5%,0.75% for 100%,150% level from the target concentration of Dapaglifozin impurities spiked in sample preparation and analyzed with unspiked sample preparation, recorded the chromatogram. Six preparation for 50%,150% level and triplicate preparation of median level concentration were done. Results are summarized in Table 7.

Table 7: Result of Recovery of LOQ to 150%.

Name Level %Recovery %RSD
  LOQ 98.6 2.9
  50% 92.2 3.6
Impurity-I 100% 97.6 0.7
  150% 94.1 3.5
  LOQ 100 1.5
  50% 113.9 2.1
Impurity-II 100% 110.2 0.8
  150% 90.9 0.8
  LOQ 113.1 1.8
  50% 111.5 1.6
Impurity-III 100% 104.6 0.8
  150% 96.3 1.1
  LOQ 105.1 5.3
  50% 118.9 1.5
Impurity-IV 100% 114.8 0.6
  150% 93.1 0.7
  LOQ 110.4 1.2
  50% 110.1 1
Impurity-V 100% 100.1 1.1
  150% 93.9 2.1
  LOQ 119.1 3.4
  50% 112.8 0.3
Impurity-VI 100% 113.3 1.8
  150% 93.2 1.9

Robustness

Robustness of the current method was investigated by analyzing the standard solution and established system suitability with the deliberate variation of flow rate,column temperature and pH of Buffer at 10 percentage level from the original value. RSD of six replicate injections of standard solution was found below 5.0% for all the chromatographic condition and all peaks in standard solutions.

The conditions with the variation and the results are presented in Tables 8-10.

Table 8: Robustness (Column Temperature).

  Normal Condition Column Tem + Column Tem -
Name RRT Resolution RRT Resolution RRT Resolution
Impurity-I 0.65 - 0.66 - 0.66 -
Dapaglifozin 1 30.5 1 30.1 1 30.7
Impurity-III 1.09 7.9 1.11 7.3 1.09 7.9
Impurity-II 1.11 1.9 1.13 1.8 1.11 1.9
Impurity-V 1.38 22 1.38 21.7 1.37 21.9
Impurity-VI 1.74 28.7 1.76 28.4 1.74 28.9
Impurity-IV 1.93 15 1.95 15.2 1.91 15.4

Table 9: Robustness (Flow Rate).

  Normal Condition Flow + Flow -
Name RRT Resolution RRT Resolution RRT Resolution
Impurity-I 0.65 - 0.66 - 0.67 -
Dapaglifozin 1 30.5 1 29.6 1 30.7
Impurity-III 1.09 7.9 1.1 7.5 1.09 7.8
Impurity-II 1.11 1.9 1.12 1.8 1.11 1.9
Impurity-V 1.38 22 1.39 22.2 1.38 22.2
Impurity-VI 1.74 28.7 1.77 28.6 1.76 28.3
Impurity-IV 1.93 15 1.94 15.1 1.9 15.6

Table 10: Robustness (pH of Buffer).

  Norma l Condition   pH +   pH -
Name RRT Resolution RRT Resolution RRT Resolution
Impurity-I 0.65 - 0.66 - 0.64 -
Dapaglifozin 1 30.5 1 30.6 1 30.2
Impurity-III 1.09 7.9 1.1 7.9 1.08 7.8
Impurity-II 1.11 1.9 1.12 1.9 1.1 1.8
Impurity-V 1.38 22 1.38 22.1 1.37 21.9
Impurity-VI 1.74 28.7 1.76 28.9 1.71 28.6
Impurity-IV 1.93 15 1.94 14.6 1.88 15

LOD & LOQ

LOD and LOQ were calculated by using the formula 3.3S.D/S and 10S.D/S where S.D is the standard deviation of Y-intercept and S is the slope of the calibration curve (Table 11).

Table 11: LOD and LOQ of Dapaglifozin and its Impurities.

Name LOD LOQ
Dapaglifozin 0.02% 0.05%
Impurity-I 0.02% 0.05%
Impurity-II 0.02% 0.05%
Impurity-III 0.02% 0.05%
Impurity-IV 0.02% 0.05%
Impurity-V 0.02% 0.05%
Impurity-VI 0.02% 0.05%

Force Degradation

(Tables 12 and 13) and (Figures 15-20).

Table 12: Force Degradation sample condition.

Sample Condition
Acid 5N HCL (5mL) 80°C, 18Hrs
Base 1N NaOH (5mL) 80°C, 18Hrs
Peroxide 30%H2O2(1mL) 80°C, 8Hrs
Thermal 80°C, 24hrs
Photo Sun Tester, 1.2 Lux/Hrs, 24Hrs
Humidity 75%RH, 24Hrs

Table 13: Result of Force Degradation study.

Sample Imp-I Unk-1 Unk-2 Unk-3 Unk-4 Unk-5 Total Imps Assay Mass Balance Purity Angle Purity Threshold
Acid 0.1 5.8 4.2 0.03 0.07 0.11 10.31 89.7 100.2 0.214 0.296
Base 0.08 0.12 0.06 0.03 0.08 0.09 0.46 99 99.6 0.14 0.393
Peroxide 0.18 0.02 0.05 0.04 0.07 0.09 0.47 99.5 100.1 0.443 0.505
Thermal 0.12 0.02 0.04 0.03 0.07 0.05 0.34 100.2 100.7 0.41 0.531
Photo 0.03 0.09 0.05 0.06 0.1 - 0.33 98.2 98.7 0.37 0.507
Humidity 0.02 0.11 0.03 0.08 0.11 0.02 0.37 98.9 99.5 0.38 0.484

Figure 15: Chromatogram of Base Degradation sample.

Figure 16: Chromatogram of Peroxide Degradation sample.

Figure 17: Chromatogram of Thermal Degradation sample.

Figure 18: Chromatogram of Photo Degradation sample.

Figure 19: Chromatogram of Humidity Degradation sample.

Figure 20: Chromatogram of Acid Degradation sample.

Solution Stability

Solution stability optimized by injected standard solution at different time interval and calculated % deviation against initial area of standard solution. It was found that standard and sample were stable up to 72 hrs. Results are presented in Table 14.

Table 14: Result of Stability of Standard Solution.

Standard Solution
Time (Hrs) Area % Deviation
Initial 116589 -
26 116874 0.24
36 117058 0.4
45 117985 1.2
60 118054 1.26
72 119524 2.52

Conclusion

A novel, reverse phase liquid chromatographic method has been developed and validated for the estimation of Dapaglifozin and its impurities with a very recent and advanced HPLC method. The proposed method is found to be simple, accurate, precise, sensitive, specific and robust. Hence, it can be successfully used for the routine analysis of Dapaglifozin in pharmaceutical dosage forms.

Acknowledgement

The author would like to thank guide Mrs.Sejal Patel and all family members for their valuable support throughout the work. The Authors acknowledge Ganpat University and Shree S. K. Patel College of Pharmaceutical Education and Research for providing the infrastructure facility for carrying out this work.

References

1. Pratley E, McCall,T,Fleck, P,Wilson, C,Mekki Q.“Alogliptin use in elderly people: A pooled analysis from phase 2 and 3 studies”. Journal of the American Geriatrics Society. 2009; 57: 2011-2090.

2. Bajaj M, Briones M. “Exenatide: A GLP-1 receptor agonist as novel therapy for type-2 diabetes mellitus”, Expert opinion on pharmacotherapy. 2006; 7: 1055-1064.

3. Bennett W, Maruthur N, Singh S, Segal J, Wilson L, Chatterjee R, et al. “Comparative effectiveness and safety of medications for type-2 diabetes: An update including new drugs and 2-drug combinations”. Annals of Internal Medicine. 2011; 154: 602-613.

4. Tatarkiewicz K, Polizzi C, Villescaz C, D’Souza LJ, Wang Y, Janssen S, et al. Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice. Diabetes, Obesity and Metabolism. 2013; 16: 376-380.

5. Sanagapati M, Lakshmi D, Reddy N, Sreenivasa S. Development and validation of stability - Indicating RP-HPLC method for determination of dapagliflozin. J Adv Pharm Edu Res. 2014; 4: 350-353.

6. Drug Bank: Dapagliflozin (DB06292).

7. U.S. Food and Drug Administration Guidance for Industry, ICH Q3A, Impurities in New Drug Substances. 2003.

8. U.S. Food and Drug Administration Guidance for Industry, ICH Q3B, Impurities in New Drug Products, 2006.

9. U.S. Food and Drug Administration Guidance for Industry, ICH Q3C, Impurities: Residual Solvents. 1997.

10. U.S. Food and Drug Administration Guidance for Industry, ICH Q6A Specifications: Test Procedure and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. 1999.

11. ICH. Stability testing of new Drug substances and products, International Conference on Harmonisation, IFPMA, Geneva. 1993.

12. ICH. Impurities in new drug products, International Conference on Harmonisation, IFPMA, Geneva. 1996.

13. ICH. Specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances. International Conference on Harmonisation, IFPMA, Geneva. 1999.

Other Articles

Article Image 1

Removal of Acid Beverage Flocs in Crystal Sugar by Adsorption Column Chromatography: Preliminary Study with Adsorbent Resin

The sugar industry has been facing some problems with white sugar intended for soft drinks production. Some studies have been demonstrated the sugar could be source of insoluble substances technically called by Acid Beverage Flocs (ABF). It appears during the beverage production; however, the flocs are easily disappearing with shaking. This may be related to raw material the sugarcane quality and, consequently, with the efficiency of the juice clarification process, since if there is no adequate juice treatment. The sugarcane commonly has lower quality and higher intensity of impurities, such as proteins, wax, minerals and colloids. The sugar industries are implementing solutions to reduce the amount of impurities through using technologies like ionic resins to removal of color, odor or undesirable taste. It could transform raw sugar in refined or white sugars. The aim of this work was evaluate the efficiency of purification of sugar solution with chromatographic adsorption system. We observed that the color reduction was around 69% and an intensive reduction in turbidity of sugar aqueous solution. There were variation on sucrose and increase on reducing sugars (glucose and fructose) contents. It is possible to conclude that the process could be efficient to reduce the color (MAU color), turbidity and ABF into sugar solutions.

Roberta Bergamin Lima and Claudio Lima de Aguiar*


Article Image 1

A Study to Evaluate Aflatoxin Contamination in Food from Gauteng Province

Aflatoxins (AFs) and their producers have been found to be problematic and is still an issue. This is due to their role in influencing food quality, health and economy loss. In maintaining good food quality, minimize AFs occurrence and its deleterious effects, it is essential that issues relating to mycotoxin production and contamination are monitored, and addressed on a regular basis. This will proffer suggestions for immediate actions to be taken, in order to achieve and maintain regulatory limit before situations are out of control. Hence the case study to evaluate the concentration of AFs in food, by way of thin layer chromatography and high performance liquid chromatography was attempted. This is to monitor concentrations of the emerging mycotoxin in relation to international regulatory limits. Concentrations levels ranging 0.06 - 77.97 ppb was observed, (mean: 16.8 ppb) and measured out in the food samples of study, exceeding the ISO limits (0.05 ppb). This calls for proper monitoring of pre and postproduction stages in food, by employing easy to use chromatographic techniques as a routine process to screen and ascertain concentrations do not exceed regulatory limits.

Henry E Iheanacho¹,²,³*


Article Image 1

Investigation of Naturally Occurring Fumonisin B1 and Glycated Fumonisin B1 in Korean Feedstuffs

Mycotoxins are potentially dangerous contaminants of livestock feeds. In this study, we measured the levels of fumonisin B1 and glycated fumonisin B1 in feedstuffs and then investigated the ability of the extrusion heating regimen to convert the most prevalent mycotoxin contaminant, fumonisin B1 , to a less toxic glycated form. All feed samples were analyzed with fully validated methods. All measured concentrations of fumonisin B1 were below harmful thresholds, including European Union-recommended levels or US Food and Drug Administration action levels.

Because fumonisin B1 was highly contaminated mycotoxin in our present investigation and fumonisin B1 has been shown to be less toxic following Maillard type reaction with reducing sugar, we examined the formation of fumonisin B1 derivatives by Maillard reaction under extrusion process conditions. We employed a variety of tandem mass spectrometric methodologies to selectively detect fumonisin B1 derivatives and to elucidate their structures partially. We found that compounds of m/z 736 were more likely artifacts or side reaction products rather than glycation products. N-(carboxymethyl) fumonisin B1 of m/z 780 and other major glycation products of m/z 794 and 810 were not detected, and only negligible amounts of methylene fumonisin B1 was found in 10 extruded feed samples. Therefore, either the tested extrusion conditions did not induce fumonisin B1 glycation or the glycation products simply could not be detected by the method employed in this study.

Jongsung Ahn¹, Hyenjong Kim¹, and Kwang-Yeop Jahng²*


Article Image 1

Determination of HMF in Some Instant Foods and Its Biodegradation by Some Lactic Acid Bacteria in Medium and Food

The aims of this study were to determine HMF level in some foods and to reduce their level by biodegradation. Coffee whitener, cappuccino, hot chocolate, instant coffee, instant powdered mix (coffee, coffee whitener and sugar) and aromatized cocoa were subjected to HMF analysis in the scope of this study. The HMF determination of samples was carried out using a high performance liquid chromatography. Color properties of the samples were determined according to standard procedures and their relations with HMF content were also investigated. The biological degradation of HMF with lactic acid bacteria was also studied with broth media and a model food system (reconstituted milk).The average HMF levels were 12.59 mg/kg for coffee whitener, 572.49 mg/ kg for cappuccino, 660.29 mg/kg for hot chocolate, 1804.91 mg/kg for instant coffee, 871.56 mg/kg for instant powdered mix and 980.94 mg/kg for aromatized cocoa. The addition of lactic acid cultures reduced the HMF content of the samples. HMF levels of broth media and model food inoculated with lactic acid bacteria (L. lactis, L.bulgaricus, L. cremoris) decreased about 25 % as a result of HMF biodegradation.

Rasim Alper Oral¹, Mahmut Dogan², Kemal Sarıoglu², Ahmed Kayacıer¹, and Osman Sagdic³*


Article Image 1

An Integrated Analysis of the Musa Paradisiaca Peel, Using UHPLC-ESI, FT IR and Confocal Microscopy Techniques

When the banana (Musa paradisiaca) peel was subject of enzymatic hydrolysis with cellulase and hemicellulase, only glucose was obtained. Images from banana peel, using confocal laser scanning microscopy, demonstrate that the cellulose is the main structural compound. Fatty acids, phenolic and other compounds were detected from the organic residual extract, and characterized by means of NMR, FT-IR and UHPLC-MS techniques. The presences of these compounds were corroborated through a steam distillation. Under this condition, banana peel could have potential applications in the food field, where could be used to improve some procedures such as the obtaining of banana vinegar.

Miriam Alejandra González Corona¹, Mayra Beatriz Gómez-Patiño², María de Jesús Perea Flores², Luis Alberto Moreno Ruiz², Blanca Margarita Berdeja Martinez¹, and Daniel Arrieta-Baez²*


Article Image 1

Structural Characterization of Bamboo Lignin Isolated With Formic Acid and Alkaline Peroxide by Gel Permeation Chromatography and Pyrolysis Gas Chromatography Mass Spectrometry

Fractionation is an effective technology to maximize the utilization of lignocelluloses for the production of chemicals and materials. In this case, bamboo was subjected to a two-step fractionation process based on the concept of biorefinery: (a) formic acid treatment at boiling point under atmospheric pressure for 2 h, and (b) post treatment with alkaline hydrogen peroxide solution containing 1% NaOH and 1% H2 O2 at 80 ºC. The combination of formic acid delignification and alkaline hydrogen peroxide degradation achieved an effective removal of both lignin (delignification rate 94.9%) and hemicelluloses (removal rate 87.4%) from bamboo, producing cellulose rich pulp, formic acid lignin and sugars. To investigate the structural modification of lignin during the fractionation process, the residual lignin in the treated samples was isolated and characterized with multiply techniques including gel permeation chromatography, pyrolysis gas chromatography mass spectrometry, Fourier-transform infrared spectroscopy, etc. The relative ratio of S/G was 1.63 for bamboo milled wood lignin (L1), whereas the lignin isolated from the formic acid treated cellulose-rich fraction (L2) presented a chromatograph similar to that of L1 but had a lower S/G ratio of 1.28. This indicated that a preferential removal of S units during the formic acid fractionation process. In addition, alkaline hydrogen peroxide treatment resulted in more removal of S units, as indicated by a lower S/G ratio of 0.71.

Xun Li¹, Chang-Zhou Chen¹, and Ming-Fei Li¹*

 


Article Image 1

Volatile Compound Profiles by HS GC MS for the Evaluation of Postharvest Conditions of a Peach Cultivar

Volatile Organic Compounds (VOCs) profile of foods obtained by Gas Chromatography/Mass Spectrometry (GC/MS) can be considered a potent tool of food products quality changes occurring as a result of different processing, such as ripening and deterioration. The aim of the present study was the evaluation of volatiles profiles of peaches (cv Springcrest) during their storage in conditions similar to those of long distance transport that normally these products undergo before being placed on market. We investigated control sample (no stored fruit) and peaches stored in cardboard boxes wrapped in heat-sealed HD polythene bags, both in normal and modified atmosphere (0% and 23% CO2 ) after 1 and 8 days of storage at 4°C. GC/MS analysis of these samples allowed the identification of a total of 115 VOCs.

The comparison of the VOCs profile of the three peach samples (control, normal atmosphere and 23% CO2 ) shows that fruits packaged in normal atmosphere released a greater amount of esters of medium chain fatty acids, such as ethyl nonanoate and ethyl dodecanoate. On the other hand, fruits stored in normal atmosphere and modified atmosphere after 8 days of storage (increased concentration of CO2 in packs) released a greater amount of esters of long chain fatty acids, such as ethyl hexadecanoate.

Livia Malorni¹, Antonella Martignetti¹, and Rosaria Cozzolino¹*


Article Image 1

Current Trends in Lignocellulosic Analysis with Chromatography

The conversion of lignocellulosic biomass into biofuel and biomaterial is promising for the substitution of fossil resources in energy and material applications. Given the complexity of plant cell wall, the main challenge is to obtain lignocelluloses with high yield and purity. For a better understanding of lignocellulosic biomass, chromatography stands out as a powerful separation method that can support the lab directed research and pilot scale production of biomaterial and biochemical. This paper provides a review on the characterization of cellulose, hemicellulose and lignin along with their derivatives and decomposed sugar monomers, in particular their isolation and purificationmethods using various specific types of chromatography. Methods with various specific types of chromatography. This review also summarizes different chromatographic methods for obtaining the molecular weights of cellulose, hemicellulose and lignin that have been used in recent years, and highlights future opportunities for the application of those biopolymers.

Fengbo Sun¹ and Qining Sun²*


Article Image 1

Current Status of Two-Dimensional Gel Electrophoresis and Multi-Dimensional Liquid Chromatography as Proteomic Separation Techniques

Proteomics is very important component in the era of post-genomics because it can address functions of genes and some important non-gene-determined biological issues such as Post Translational Modifications (PTMs), splicing, translocation, and spatial structure. Proteome is very complex, including multiple parameters such as kind of proteins, copy number of each protein, PTMs, isoforms, spatial structure of each protein, protein-protein interaction, and protein-other molecule interaction, etc. Moreover, proteome is dynamic, and alters with different conditions such as different physiological processes, different pathological processes, and different disease status.

Xianquan Zhan¹,²,³,⁴*


Article Image 1

Validation of Assay Indicating Method Development of Imatinib in Bulk and Its Capsule Dosage Form by Liquid Chromatography

A novel, simple and economic reverse phase High Performance Liquid Chromatography (RP-HPLC) method has been developed for the quantification of Imatinib in bulk and capsule dosage form with greater precision and accuracy. Separation was achieved on Analytical technologies, C-18, (250mm*4.6mm) column in isocratic mode with mobile phase consisting of acetonitrile: potassium dihydrogen phosphate buffer (pH 2.5) (30:70v/v) with a f low rate of 0.8 mL/min. The detection was carried out at 268 nm. The retention time of Imatinib was found to be 2.67 min. The method was validated as per ICH guidelines. Linearity was established for Imatinib in the range 5-35 μg / ml with r2 value 0.996. The percentage recovery of Imatinib was found to be in the range 99.49-99.67 %. The high recovery and low relative standard deviation confirm the suitability of the proposed method for the estimation of the drug in bulk and capsule dosage forms. Validation studies demonstrated that the proposed RP-HPLC method is simple, specific, rapid, reliable and reproducible for the determination of Imatinib for quality control level.

Nalini Kanta Sahoo¹, Madhusmita Sahu¹, V Alagarsamy¹, B Srividya², and Chinmaya Keshari Sahoo³*